COMMUNIQUÉS West-GlobeNewswire

AC Immune Shares Insights from Key Opinion Leader Meeting on Tau as a Therapeutic and Diagnostic Target in Alzheimer's and other Neurodegenerative Diseases

01/12/2017 - 20:20

Lausanne, Switzerland, December 1, 2017 - AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, shared the top level insights [...]

NICOX : Number of voting rights as of November 30. 2017

01/12/2017 - 17:46

Nicox SA Société anonyme with a registered capital of € 29,169,338 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On December 1, 2017, MONTHLY PUBLICATION OF THE [...]

NICOX : Nombre total de droits de vote au 30 novembre 2017

01/12/2017 - 17:46

Nicox SA Société anonyme au capital de 29 169 338 euros Siège social : DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 Le 1 er décembre 2017, PUBLICATION MENSUELLE DU NOMBRE D' [...]

Medtronic EVP & RTG President Geoff Martha to Speak at Citi Global Healthcare Conference

01/12/2017 - 17:01

DUBLIN - December 1, 2017 - Medtronic plc (NYSE: MDT ), the global leader in medical technology, today announced that it will participate in the Citi 2017 Global Healthcare Conference on Wednesday, December 6, 2017, in [...]

NAPA’s Sonia Szlyk to Present at Interdisciplinary Conference on Orthopedic Innovations

01/12/2017 - 17:00

MELVILLE, N.Y., Dec. 01, 2017 (GLOBE NEWSWIRE) -- North American Partners in Anesthesia (NAPA) announced today that Sonia Szlyk, MD, Director of Regional Anesthesia for NAPA’s mid-Atlantic region will be a featured [...]

Emblem Announces Commencement of Nick Dean as Chief Executive Officer and President

01/12/2017 - 15:00

TORONTO, Dec. 01, 2017 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (EMC.WT) (“ Emblem ” or the “ Company ”) is pleased to announce that Nick Dean has commenced his role as the Chief Executive Officer and President of [...]

Matrix Medical Network completes the acquisition of LP Health Services

01/12/2017 - 15:00

SCOTTSDALE, Ariz., Dec. 01, 2017 (GLOBE NEWSWIRE) -- Matrix Medical Network, the industry leader in providing in-home assessments and comprehensive care management services to health plan members, today announced that [...]

Coherus BioSciences Management to Present at BMO’s Prescriptions for Success Healthcare Conference

01/12/2017 - 15:00

REDWOOD CITY, Calif., Dec. 01, 2017 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS ) today announced that senior management will be participating in a fireside chat at the BMO Prescriptions for Success [...]

AIT Therapeutics Announces Publication of Its Phase 2 Trial in Bronchiolitis Patients in the Pediatric Pulmonology Journal

01/12/2017 - 14:45

NEW YORK, Dec. 01, 2017 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (OTC:AITB), a clinical-stage biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with serious lung [...]

Canada House Wellness Group Announces Increase in Convertible Debenture Unit Financing to $6 Million

01/12/2017 - 14:30

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 01, 2017 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“ Canada House ” or the “ Company ”) is pleased [...]

Caladrius Biosciences to Present at the 10th Annual LD Micro Main Event

01/12/2017 - 14:30

BASKING RIDGE, N.J., Dec. 01, 2017 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ: CLBS ) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms [...]

3D Signatures Inc. Announces Upsizing of $1,500,000 Private Placement, the Appointment of a New Director and Reports on AGM Results

01/12/2017 - 14:15

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 01, 2017 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V: DXD ) (OTCQB:TDSGF) (FSE:3D0) (the " Company " or " 3DS ") [...]

Aphios is Developing a Platform for the Delivery of siRNA-based Therapeutics Towards an HIV Cure

01/12/2017 - 14:00

WOBURN, Mass., Dec. 01, 2017 (GLOBE NEWSWIRE) -- Aphios Corporation today announced that it is developing a platform for the effective targeted delivery of siRNA-based Therapeutics with funding from the National [...]

Extendicare Announces Appointment of Al Mawani to Board of Directors

01/12/2017 - 14:00

MARKHAM, Ontario, Dec. 01, 2017 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) today announced the appointment of Al Mawani to its Board of Directors, effective immediately, for a term [...]

Athenex Announces Planned Retirement of Chief Financial Officer Nick Riehle

01/12/2017 - 14:00

BUFFALO, N.Y., Dec. 01, 2017 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]

California Medical Groups Honored for High-Quality Care of Medicare Advantage Patients

01/12/2017 - 14:00

OAKLAND, Calif., Dec. 01, 2017 (GLOBE NEWSWIRE) -- Almost a third of medical groups statewide achieved top honors for providing high-quality care to Medicare Advantage patients, according to the Integrated Healthcare [...]

AzurRx BioPharma to Present at the 2017 LD Micro 10th Annual Main Event Conference (December 5th)

01/12/2017 - 13:30

BROOKLYN, N.Y., Dec. 01, 2017 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc.(NASDAQ: AZRX ) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal [...]

Faron Pharmaceuticals Oy: Appointment of Chief Commercial Officer

01/12/2017 - 13:00

Faron Pharmaceuticals Oy ("Faron" or the "Company") Appointment of Chief Commercial Officer Dr. Juhana Heinonen, previously AstraZeneca's Global Marketing Director, to steer commercialisation strategy for Faron's lead [...]

Curis Announces Upcoming Presentation at the American Society of Hematology 59th Annual Meeting & Exposition

01/12/2017 - 13:00

LEXINGTON, Mass., Dec. 01, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ: CRIS ), a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for the treatment of [...]